ORKA FY 2022 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ORKAOruka Therapeutics, Inc.

$1B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$114,000

Operating Income

-$10M

Net Income

-$10M

EPS (Diluted)

$-8.27

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$43M

Total Liabilities

$1M

Stockholders' Equity

$42M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$114,000	-$91,000	-25.3%
Operating Income	-$10M	-$19M	+49.1%
Net Income	-$10M	-$19M	+48.6%